ONE-YEAR TRIAL OF A REMOTE-CONTROLLED IMPLANTABLE INSULIN INFUSION SYSTEM IN TYPE I DIABETIC PATIENTS
- 15 October 1988
- journal article
- Published by Elsevier in The Lancet
- Vol. 332 (8616) , 866-869
- https://doi.org/10.1016/s0140-6736(88)92469-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Atherosclerosis in diabetes: The role of hyperinsulinemiaMetabolism, 1988
- Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study.BMJ, 1986
- Blood Glucose Control and the Evolution of Diabetic Retinopathy and AlbuminuriaNew England Journal of Medicine, 1984
- EFFECT OF 1 YEAR OF NEAR-NORMAL BLOOD GLUCOSE LEVELS ON RETINOPATHY IN INSULIN-DEPENDENT DIABETICSThe Lancet, 1983
- A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSIIDiabetes Care, 1982
- A Remotely Programmable Insulin Delivery SystemPublished by American Medical Association (AMA) ,1982
- Long-term Continuous Intraperitoneal Insulin Infusion with an Implanted Remote-Controlled Insulin Infusion DeviceDiabetes, 1981
- The Intravenous, Intraperitoneal, and Subcutaneous Routes of Insulin Delivery in Diabetic ManDiabetes, 1979
- Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.BMJ, 1978
- One to Five Days of Continuous Intravenous Insulin Infusion on Seven Diabetic PatientsDiabetes, 1974